Eisner Mark

EVP and Chief Medical Officer at VIR; Officer at FGEN

Sold, on record
$721k
Dollars the filings state
Form 4 sales
8
Latest Feb 25, 2026
Form 144 notices
2
Proposed sales
Companies
2
Filed as an executive or holder

Companies

  • VIRVir Biotechnology, Inc.EVP and Chief Medical Officer
  • FGENKYNTRA BIO, INC.Officer

Sales by reason

2
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale FGENNo plan
    Apr 4, 2023 2023

    Sold 9,182 shares at $18.78 ($172k)

    Eisner Mark, Chief Medical Officer

    No 10b5-1 planSold 5.2% of holdings ($3.3M position)165,994 shares leftFiling

  2. 2 Form 144 notice FGENNotice
    Jun 2, 2023 +59 days

    Filed to sell 1,090 shares ($21k)

    Eisner Mark, Officer

    No 10b5-1 plan0.1x usual sizeFiling

  3. 3 Form 4 sale FGENNo plan
    Jun 2, 2023 same day

    Sold 1,090 shares at $18.83 ($21k)

    Eisner Mark, EVP, Chief Medical Officer

    No 10b5-1 planSold 0.7% of holdings ($3.1M position)164,904 shares left0.1x usual sizeFollows a Form 144Filing

  4. 4 Form 144 notice FGENNotice
    Jun 7, 2023 +5 days

    Filed to sell 2,042 shares ($35k)

    Eisner Mark, Officer

    No 10b5-1 plan0.4x usual sizeFiling

  5. 5 Form 4 sale FGENNo plan
    Jun 7, 2023 same day

    Sold 2,042 shares at $17.04 ($35k)

    Eisner Mark, EVP, Chief Medical Officer

    No 10b5-1 planSold 1.2% of holdings ($2.8M position)162,862 shares left0.4x usual sizeFollows a Form 144Filing

  6. 6 Form 4 sale VIRRoutine
    Jul 17, 2025 +771 days

    Sold 10,382 shares at $5.47 ($57k)

    Eisner Mark, EVP and Chief Medical Officer

    10b5-1 planSold 9% of holdings ($629k position)104,618 shares leftFirst sale on recordFiling

  7. 7 Form 4 sale VIRRoutine
    Feb 23, 2026 +221 days

    Sold 2,089 shares at $7.45 ($16k)

    Eisner Mark, EVP and Chief Medical Officer

    10b5-1 planSold 1.3% of holdings ($1.2M position)157,529 shares leftFiling

  8. 8 Form 4 sale VIRRoutine
    Feb 25, 2026 +2 days

    Sold 3,505 shares at $9.69 ($34k)

    Eisner Mark, EVP and Chief Medical Officer

    10b5-1 planSold 2.2% of holdings ($1.5M position)154,024 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (10)

Form 144 notices and Form 4 sales by Eisner Mark
Source
Feb 25, 2026Feb 26, 2026VIREVP and Chief Medical OfficerForm 4 sale3,505$34k2.2%RoutineSEC
Feb 23, 2026Feb 24, 2026VIREVP and Chief Medical OfficerForm 4 sale2,089$16k1.3%RoutineSEC
Jul 17, 2025Jul 17, 2025VIREVP and Chief Medical OfficerForm 4 sale10,382$57k9.0%RoutineSEC
Jun 7, 2023Jun 9, 2023FGENEVP, Chief Medical OfficerForm 4 sale2,042$35k1.2%No planSEC
Jun 7, 2023Jun 7, 2023FGENOfficerForm 144 notice2,042$35kNoticeSEC
Jun 2, 2023Jun 5, 2023FGENEVP, Chief Medical OfficerForm 4 sale1,090$21k0.7%No planSEC
Jun 2, 2023Jun 2, 2023FGENOfficerForm 144 notice1,090$21kNoticeSEC
Apr 4, 2023Apr 6, 2023FGENChief Medical OfficerForm 4 sale9,182$172k5.2%No planSEC
Mar 10, 2023Mar 10, 2023FGENChief Medical OfficerForm 4 sale17,503$361k9.1%Plan not statedSEC
Mar 2, 2023Mar 6, 2023FGENChief Medical OfficerForm 4 sale1,187$26k0.7%Plan not statedSEC